Particle Accelerators Create Potential Cancer Treatment in Lansing

A Lansing company called Niowave has begun producing actinium-225, a silvery metal isotope that barely exists on Earth, with a superconducting linear accelerator. The reason? This isotope is a promising cancer treatment; however, researchers don’t know its full potential due to the absence of clinical trials. 

Niowave has secured a $5 million deal with Fusion Pharmaceuticals to start production in 2024.  Between Russia, the United States, Germany, and Canada, there are only two curies (unit of measurement for radioactive materials) of actinium-225. Niowave plans on making one curie per week. 

In 2019, the federal government gave Niowave $15 million, and another $13 million last year, to produce molybdenum 99, which is used for medical imaging. Since other countries subsidize its production, making a profit from molybdenum 99 is tricky. 

After working with uranium for years, the federal government determined Niowave could function safely with another highly radioactive element, radium, to create actinium-225. 

Cancer therapy isotopes emit beta particles, which can destroy cancer cells but also kill healthy cells around them. Actinium-225 delivers more targeted alpha particles, which can emit more energy at a shorter distance.

Justin Wilson, an associate professor of chemistry and chemical biology at Cornell University said, “If you can get those alpha particles to the cancer cells, they have the capability of doing more damage but in a more confined region. Which, in theory, could prevent hitting healthy cells that maybe aren’t part of the small metastatic lesion.” 

Eric Burak, chief technical officer at Fusion Pharmaceuticals, states that they are working on formulating three separate drugs that use actinium-225. He said the isotope is “One of the rarest elements in the entire planet, and, with more companies interested in its therapeutic potential, everyone is scrambling for actinium supply.” 

Fusion Pharmaceuticals are investing $5 million to help Niowave create actinium-225 in exchange for a guaranteed share of the end result. 

Niowave’s superconducting linear accelerator has been moved to a concrete room as radium is extremely radioactive. 

_______________________________

RadParts is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerator and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost parts and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

 

Novel Cancer Treatment Headed to McLaren Flint

An innovative new technology headed to Flint will be used to treat cancer with proton therapy. The McLaren Proton Therapy Center is the first to receive the new machine that treats patients upright, enabling cancer treatment with more precision. 

Leo Cancer Care developed the proton therapy called “Marie,” which will take up less space yet provide more accurate treatments since there will be less organ movement. 

The Proton Therapy Center in Flint will receive the first two upright units and be used within the next two years, pending FDA approval. The largest proton center in Michigan, the new machine will allow more patients to be treated. 

According to a news release from McLaren, proton therapy is a type of radiation therapy that uses protons to accurately target tumor cells and leave healthy surrounding cells undamaged.

Stephen Towe, CEO of Leo Cancer Care, said, “The goal of Leo Cancer Care and McLaren Proton Therapy Center’s collaboration is to bring proton therapy to more patients, and we know there are clear advantages with proton therapy. The McLaren Proton Therapy Center is well-positioned to become the first to potentially treat patients with the revolutionary Leo Cancer Care technology.”

Construction to add the “Marie” units to the Proton Therapy Center in Flint will start in the spring of 2023 and be fully operational by the fall of 2024.  

--------------------------------------------------------

RadParts is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerator and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost parts and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/ 

 

Deciphering the Difference Between Critical and Mundane Tasks in Radiology

 

Successful people who thrive in their careers are typically engaged in their workload and manage responsibilities well, with a keen focus uninterrupted by distractions. Generally, it isn’t too difficult to decipher actual “work” from mundane tasks that are counterproductive or irrelevant, yet many people are guilty of partaking in the latter more often than not. 

Diagnostic radiologists are typically responsible for interpreting images and providing reports outlining the findings. Whether certain clinical questions, managerial roles, or imaging protocols are involved, the overall group functions more efficiently when everyone is equally engaged. 

Once in a while, radiologists might feel like they are partaking in mundane activities; for example, if a reporting template doesn’t match their personal style or search pattern. Another scenario might include defending one’s reporting language against a hypercritical QA reviewer. 

Based on what the radiologist believes their work should encompass, one radiologist’s critical tasks are another’s. 

To bridge the gap between critical and mundane tasks, one must note the subtle perverse incentives that might be happening in the workplace. Government, regulatory, and academic fields all succumb to these inadequacies when someone is rewarded for bad behavior or punished for good.

Common issues in radiology include no reward for productivity or no survey of who is contributing to the overall team effort. Radiologists who produce more RVUs might be extra stressed, which increases malpractice liability, both of which are perverse disincentives. To regain equilibrium, the radiologist can reduce their efforts or take more breaks, for example.

When certain team members become more aware of their performance impediments, better tools, more personnel, etc., are appointed. Once leadership is alerted, staff surveys are performed, which could lead to new hardware, software, coworkers, and more. 

Without any sign of stress in the system, those who rank higher on the totem pole are unable to specifically outline any issues or provide support. However, with help from other team members through surveys and the like, leadership can improve the situation based on feedback. 

Constructive evaluation and prevention is key in reducing perverse incentives and increasing overall morale. 

RadParts is the world’s largest independent distributor of OEM replacement parts. We specialize in low-cost parts for repairing linear accelerator and radiation equipment. Our mission is to provide high-quality, user-friendly, low-cost parts and support for linear accelerators and radiation equipment. Contact RadParts at 877-704-3838 to learn more.

 

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/